معرفی
Kelly Walton is an Adjunct Lecturer in Physiology at Monash University, co-heading the Growth Factor Therapeutics Laboratory. She holds a PhD from Swinburne University (2008) and previously worked at Prince Henry’s Institute of Medical Research. Her research focuses on TGF-β biology, inhibin activity, and activin signaling in cancer cachexia and metabolic disorders.
- Affiliations: Monash University (2016–present), Prince Henry’s Institute (2008–2016)
- Key Projects: Targeting activin in cancer cachexia, inhibin mimetics for bone disease, and muscle wasting therapies
Research Interests: Developing therapies against muscle wasting, bone disease, and cancer-related metabolic issues. Her work combines endocrinology, molecular biology, and translational medicine.
Awards: Multiple grants and prizes, including the 2017 Newcastle Emerging Leadership Award and Monash BDI Industry Engagement Prize.
Grants: Lead investigator in projects funded by Victorian Cancer Agency, NHMRC, and Rebecca L Cooper Medical Research Foundation. Active in lab collaborations and patent filings.
Labs/Teams: Growth Factor Therapeutics Lab at Monash, collaborating on TGF-β and activin pathways.
